Cas no 113825-16-4 (5-Methyl-1H-imidazole-2-carbaldehyde)
5-Methyl-1H-imidazole-2-carbaldehyde Chemical and Physical Properties
Names and Identifiers
-
- 5-Methyl-1H-imidazole-2-carbaldehyde
- 1H-Imidazole-2-carboxaldehyde,5-methyl-
- 2-PHENYL-THIAZOL-5-YL-METHYLAMINE HYDROCHLORIDE
- 4-methyl-1H-imidazole-2-carbaldehyde
- 5-methyl-1H-Imidazole-2-carboxaldehyde
- 4-METHYL-1H-IMIDAZOLE-2-CARBOXALDEHYDE
- 4-methylimidazole-2-carbaldehyde
- BIO-FARMA BF003069
- 5-Methyl-1H-iMidazol-2-carbaldehyde
- 4-Methyl-1H-iMidazol-2-carbaldehyde
- 2-PHENYL-THIAZOL-5-YLMETHYLAMINE HCL
- 4-methyl-3H-imidazole-2-carbaldehyde
- 4-methyl-3H-imidazole-2-carboxaldehyde
- 1H-imidazole-2-carboxaldehyde, 4-methyl-
- 1H-IMidazole-2-carboxaldehyde, 5-Methyl-
- 4-Methyl-1H-iMidazole-2-carboxaldehyde 95%
- 4(5)-Methyl-1H-imidazole-2-carbaldehyde
- EN300-306019
- Z1198166211
- J-515690
- AKOS022176101
- 4-Methyl-1H-imidazole-2-carbaldehyde;1H-Imidazole-2-carboxaldehyde, 5-methyl-
- SCHEMBL321461
- AS-30542
- AM20080647
- methylimidazole-2-carbaldehyde
- DTXSID50598740
- A25816
- AB22828
- AKOS005173477
- FT-0678413
- 4-Methyl-1H-imidazole-2-carboxaldehyde, 95%
- BB 0260277
- BCP32398
- AKOS025394159
- 113825-16-4
- J-003032
- 1H-imidazole-2-carboxaldehyde, 4-methyl-;5-Methyl-1H-imidazole-2-carbaldehyde
- MFCD05864565
- CS-0342324
- DB-358373
- ALBB-011815
-
- MDL: MFCD05864565
- Inchi: 1S/C5H6N2O/c1-4-2-6-5(3-8)7-4/h2-3H,1H3,(H,6,7)
- InChI Key: AEYQOYLTLFOCHR-UHFFFAOYSA-N
- SMILES: O=CC1=NC=C(C)N1
Computed Properties
- Exact Mass: 110.04800
- Monoisotopic Mass: 110.048
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 8
- Rotatable Bond Count: 1
- Complexity: 94.4
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 45.8A^2
- XLogP3: 0.3
Experimental Properties
- Density: 1.2±0.1 g/cm3
- Melting Point: 140-145?°C
- Boiling Point: 298.8±33.0 °C at 760 mmHg
- Flash Point: 139.0±31.8 °C
- Refractive Index: 1.598
- PSA: 45.75000
- LogP: 0.53060
- Vapor Pressure: 0.0±0.6 mmHg at 25°C
5-Methyl-1H-imidazole-2-carbaldehyde Security Information
-
Symbol:
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Hazard Category Code: 22-36/37/38
- Safety Instruction: 26-36/37
-
Hazardous Material Identification:
- HazardClass:IRRITANT
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
5-Methyl-1H-imidazole-2-carbaldehyde Customs Data
- HS CODE:2933290090
- Customs Data:
China Customs Code:
2933290090Overview:
2933290090. Other compounds with non fused imidazole ring in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-Methyl-1H-imidazole-2-carbaldehyde Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 40R0035-1g |
4(5)-Methyl-1H-imidazole-2-carbaldehyde |
113825-16-4 | 96% | 1g |
1568.88CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 40R0035-5g |
4(5)-Methyl-1H-imidazole-2-carbaldehyde |
113825-16-4 | 96% | 5g |
5045.85CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 40R0035-25g |
4(5)-Methyl-1H-imidazole-2-carbaldehyde |
113825-16-4 | 96% | 25g |
16943.89CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 40R0035-500mg |
4(5)-Methyl-1H-imidazole-2-carbaldehyde |
113825-16-4 | 96% | 500mg |
1170.3CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 40R0035-250mg |
4(5)-Methyl-1H-imidazole-2-carbaldehyde |
113825-16-4 | 96% | 250mg |
975.25CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 40R0035-100mg |
4(5)-Methyl-1H-imidazole-2-carbaldehyde |
113825-16-4 | 96% | 100mg |
831.08CNY | 2021-05-07 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | M166023-250mg |
5-Methyl-1H-imidazole-2-carbaldehyde |
113825-16-4 | 95% | 250mg |
¥1276.90 | 2023-09-02 | |
| Chemenu | CM187475-5g |
4-Methyl-1H-imidazole-2-carbaldehyde |
113825-16-4 | 97% | 5g |
$791 | 2021-08-05 | |
| TRC | M321158-50mg |
4-Methyl-1H-imidazole-2-carbaldehyde |
113825-16-4 | 50mg |
$ 50.00 | 2022-06-04 | ||
| TRC | M321158-100mg |
4-Methyl-1H-imidazole-2-carbaldehyde |
113825-16-4 | 100mg |
$ 65.00 | 2022-06-04 |
5-Methyl-1H-imidazole-2-carbaldehyde Suppliers
5-Methyl-1H-imidazole-2-carbaldehyde Related Literature
-
Carla Gotzmann,Friederike Braun,Mark D. Bartholom? RSC Adv. 2016 6 119
Additional information on 5-Methyl-1H-imidazole-2-carbaldehyde
Research Brief on 5-Methyl-1H-imidazole-2-carbaldehyde (CAS: 113825-16-4): Recent Advances and Applications in Chemical Biology and Pharmaceutical Research
5-Methyl-1H-imidazole-2-carbaldehyde (CAS: 113825-16-4) is a heterocyclic aldehyde compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a key intermediate in the synthesis of various biologically active molecules, including enzyme inhibitors, antimicrobial agents, and anticancer drugs. Recent studies have explored its potential in drug discovery and development, particularly in the context of targeted therapies and combinatorial chemistry approaches.
One of the most notable advancements in the use of 5-Methyl-1H-imidazole-2-carbaldehyde is its role in the synthesis of novel imidazole-based inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent inhibitory activity against cytochrome P450 enzymes, which are critical targets in the treatment of various metabolic disorders. The study highlighted the compound's ability to form stable interactions with the heme iron center of these enzymes, thereby modulating their activity.
In addition to its enzymatic inhibition properties, 5-Methyl-1H-imidazole-2-carbaldehyde has been investigated for its antimicrobial potential. A recent report in Bioorganic & Medicinal Chemistry Letters described the synthesis of a series of imidazole-2-carbaldehyde derivatives, including 5-Methyl-1H-imidazole-2-carbaldehyde, which showed promising activity against multidrug-resistant bacterial strains. The study emphasized the compound's ability to disrupt bacterial cell wall synthesis, making it a potential candidate for the development of new antibiotics.
Another significant application of 5-Methyl-1H-imidazole-2-carbaldehyde is in the field of anticancer research. A 2022 study in the European Journal of Medicinal Chemistry explored the compound's utility as a building block for the synthesis of small-molecule inhibitors targeting protein kinases involved in cancer cell proliferation. The researchers reported that derivatives of 5-Methyl-1H-imidazole-2-carbaldehyde exhibited selective cytotoxicity against certain cancer cell lines, with minimal effects on normal cells, suggesting a favorable therapeutic window.
Recent advancements in synthetic methodologies have also enhanced the accessibility of 5-Methyl-1H-imidazole-2-carbaldehyde. A 2023 publication in Organic Letters detailed a novel, high-yield synthesis route for this compound using catalytic C-H activation techniques. This method not only improves the efficiency of production but also reduces the environmental impact compared to traditional synthetic routes, aligning with the growing emphasis on green chemistry in pharmaceutical manufacturing.
In conclusion, 5-Methyl-1H-imidazole-2-carbaldehyde (CAS: 113825-16-4) continues to be a valuable scaffold in chemical biology and pharmaceutical research. Its diverse applications, ranging from enzyme inhibition to antimicrobial and anticancer activity, underscore its potential as a key player in drug discovery. Future research is expected to further explore its mechanistic insights and expand its therapeutic applications, particularly in addressing unmet medical needs.
113825-16-4 (5-Methyl-1H-imidazole-2-carbaldehyde) Related Products
- 35034-22-1(2-Methyl-1H-imidazole-5-carbaldehyde)
- 171102-93-5(2-methyl-1H-Imidazole-4,5-dicarboxaldehyde)
- 70807-88-4(2,4-Dimethyl-1(3)H-imidazol)
- 70631-93-5(5-methyl-1H-imidazole-2-carboxylic acid)
- 118474-44-5(4,5-Dimethyl-1H-imidazole-2-carbaldehyde)
- 2524-90-5(1-(4-Methyl-1H-imidazol-2-yl)ethanone)
- 68282-52-0(2,5-dimethyl-1H-imidazole-4-carbaldehyde)
- 930-62-1(2,4-Dimethylimidazole)
- 3034-50-2(1H-Imidazole-5-carboxaldehyde)
- 88054-17-5(1H-Imidazole, 2,5-dimethyl-)